S1316, Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Constipation, Impaction, and Bowel Obstruction
- Sponsor
- SWOG Cancer Research Network
- Enrollment
- 221
- Locations
- 38
- Primary Endpoint
- Number of Days Alive and Outside of the Hospital
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This partially randomized clinical trial studies surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction. Bowel obstruction is a common problem for advanced cancer patients and can negatively affect quality of life. It is not yet known whether surgery or non-surgical management is the best treatment option for bowel obstruction and can lead to better quality of life.
Detailed Description
This partially randomized clinical trial studies surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction. Bowel obstruction is a common problem for advanced cancer patients and can negatively affect quality of life. It is not yet known whether surgery or non-surgical management is the best treatment option for bowel obstruction and can lead to better quality of life.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of Days Alive and Outside of the Hospital
Time Frame: From date of registration up to 91 days
Number of days alive and outside of the hospital
Secondary Outcomes
- Ability to Eat(Assessed at 5 weeks post registration)
- Overall Survival(From date of registration to maximum of 53 weeks)
- MDASI-GI Symptom Assessment(Assessed at 4 weeks post registration)
- NG Tube Use(During initial hospitalization, from date of registration to a maximum of 53 weeks post registration)
- Days of NG Tube Use(During entire initial hospitalization (admission to discharge) to a maximum of 53 weeks post registration)
- Number of Days in Hospital(During initial hospitalization, from date of registration to a maximum of 53 weeks post registration)